Remove 2023 Remove Biosimilars Remove Medication Therapy Management (MTM)
article thumbnail

CMS Issues Sweeping End-Of Year Rule on Medicare Advantage and Medicare Part D

Putting Patients First Blog

CMS states the proposed rule is to mitigate barriers to care, expand coverage of bariatric medications, and to implement artificial intelligence (AI) guardrails. Anti-Obesity Medication Coverage Between 2021 and 2023, the Centers for Disease Control estimated that over 40% of U.S. adults lived with obesity.

article thumbnail

NHC Submits Comments to CMS RE CY 2026 Policy & Technical Changes to MA and Part D Proposed Rule

Putting Patients First Blog

Formulary Inclusion and Placement of Generics and Biosimilars The NHC supports CMS proposals to improve formulary practices by prioritizing access to generics, biosimilars, and other cost-effective medications in the Medicare Part D program.